Ethical assessment

Ethical assessment: Bill Gates (1975–2026)

Subject: Bill Gates

View the Bill Gates ethical assessment profile

Ethical assessment categories

Ethical score profile

This assessment does not reduce the subject to one moral ranking. Each dimension is scored separately from −100 to +100 and must be read with its evidence and uncertainty.

Scorecard status: Recalculated under multidimensional system

Personal moral conduct
+75.0
Plausible range: +65.0 to +85.0
Rights and dignity
+32.9
Plausible range: +22.9 to +42.9
Nonviolence and harm
+20.0
Plausible range: +10.0 to +30.0
Stewardship of power
+85.0
Plausible range: +75.0 to +95.0
Wisdom and truthfulness
+75.0
Plausible range: +65.0 to +85.0
Consequential legacy
+68.8
Plausible range: +58.8 to +78.8
Severe-harm record
No separate finding recorded
Evidence confidence
B — high

Scope of assessment

The assessment covers Microsoft's market power, global health philanthropy, vaccination, disease eradication, agricultural development, wealth concentration and the accountability of private influence over public priorities.

The score evaluates documented public conduct during the stated period. It does not measure inherent human worth, does not constitute a legal verdict and remains open to correction when stronger evidence becomes available.

Reasoned conclusion

Gates's net ethical impact is strongly positive because large resources were converted into measurable health and development work. The score remains well below the maximum because the wealth enabling that work arose partly within an anticompetitive system and continues to confer exceptional unelected influence.

This assessment presents six separate ethical dimensions rather than one overall moral score. Each result must be read with its evidence, plausible range, confidence, disputes, exclusions, severe-harm findings and sources.

Ethical-domain scores

Domain Score Intensity Confidence
Consequences +80.0 80.0 B — high
Rights and duties +25.0 25.0 B — high
Virtue and character +20.0 20.0 B — high
Intentions +75.0 75.0 B — high
Care +85.0 85.0 B — high
Justice +40.0 40.0 B — high
Wisdom and judgment +75.0 75.0 B — high
Baseline ethics +55.0 55.0 B — high

Bipolar ethical variables

Positive pole Negative pole Score Intensity Confidence Reasoning
Human dignity Dehumanisation +55.0 55.0 B — high Calculated from 1 reviewed evidence item(s) concerning Human dignity and Dehumanisation.
Care Neglect +85.0 85.0 B — high Calculated from 1 reviewed evidence item(s) concerning Care and Neglect.
Benefit Harm +80.0 80.0 B — high Calculated from 1 reviewed evidence item(s) concerning Benefit and Harm.
Benevolent intention Malicious intention +75.0 75.0 B — high Calculated from 1 reviewed evidence item(s) concerning Benevolent intention and Malicious intention.
Justice Injustice +40.0 40.0 B — high Calculated from 1 reviewed evidence item(s) concerning Justice and Injustice.
Respect for rights Violation of rights +25.0 25.0 B — high Calculated from 1 reviewed evidence item(s) concerning Respect for rights and Violation of rights.
Integrity Corruption +20.0 20.0 B — high Calculated from 1 reviewed evidence item(s) concerning Integrity and Corruption.
Foresight Negligence +75.0 75.0 B — high Calculated from 1 reviewed evidence item(s) concerning Foresight and Negligence.

Principal positive evidence

The strongest positive evidence concerns sustained financing and advocacy for vaccination, infectious-disease control, maternal and child health and poverty reduction.

Principal negative evidence

The score is reduced by Microsoft's anticompetitive conduct, extreme concentration of wealth and the limited democratic accountability of a private foundation shaping global public-health priorities.

Evidence considered

GAT-C1

Large-scale global health and development benefit

Foundation financing and advocacy supported vaccination, disease control and health systems affecting millions of people.

Ethical axis
Benefit ↔ Harm
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-R1

Health access expanded through unelected private power

Work improved practical access to health, while concentrated private influence over public priorities lacked equal democratic participation.

Ethical axis
Respect for rights ↔ Violation of rights
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-V1

Philanthropic commitment offset by anticompetitive business conduct

Long-term giving demonstrates commitment, but Microsoft's unlawful market conduct weakens the record of fairness and integrity.

Ethical axis
Integrity ↔ Corruption
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-I1

Sustained intention to reduce disease and poverty

The foundation's long-term priorities consistently targeted severe and neglected human suffering.

Ethical axis
Benevolent intention ↔ Malicious intention
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-CA1

Material care for populations neglected by markets

Resources were directed toward diseases and health needs concentrated among poorer populations.

Ethical axis
Care ↔ Neglect
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-J1

Redistribution toward global health with structural inequality unresolved

Philanthropy redistributed substantial wealth, while the underlying concentration of ownership and agenda-setting power remained unequal.

Ethical axis
Justice ↔ Injustice
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-W1

Long-term investment in prevention and scientific capacity

The strategy prioritised vaccines, eradication and scalable systems rather than only short-term relief.

Ethical axis
Foresight ↔ Negligence
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

GAT-B1

Recognition of preventable suffering with paternalism risk

The work treats avoidable disease as morally urgent, but top-down decision-making can reduce affected communities' agency.

Ethical axis
Human dignity ↔ Dehumanisation
Ethical direction
Positive pole
Evidence status
Verified
Period
1975–2026
Affected scope
International technology and philanthropy

Disputed claims

Health outcomes are collective achievements of governments, scientists, health workers and affected communities. The assessment credits Gates only for financing, strategy and advocacy reasonably attributable to him.

Excluded claims

Conspiracy theories, unsupported medical claims and private-life allegations were excluded.

Sources

  1. Gavi's impact — Gavi, the Vaccine Alliance (2026) Evidence item GAT-B1; Supports the evidence item. View source
  2. Our Story — Gates Foundation (2026) Evidence item GAT-B1; Supports the evidence item. View source
  3. Gavi's impact — Gavi, the Vaccine Alliance (2026) Evidence item GAT-C1; Supports the evidence item. View source
  4. Global Polio Eradication Initiative — World Health Organization (2026) Evidence item GAT-C1; Supports the evidence item. View source
  5. Our Story — Gates Foundation (2026) Evidence item GAT-C1; Supports the evidence item. View source
  6. Gavi's impact — Gavi, the Vaccine Alliance (2026) Evidence item GAT-CA1; Supports the evidence item. View source
  7. Global Polio Eradication Initiative — World Health Organization (2026) Evidence item GAT-CA1; Supports the evidence item. View source
  8. Our Story — Gates Foundation (2026) Evidence item GAT-CA1; Supports the evidence item. View source
  9. Bill Gates — Gates Foundation (2026) Evidence item GAT-I1; Supports the evidence item. View source
  10. Global Polio Eradication Initiative — World Health Organization (2026) Evidence item GAT-I1; Supports the evidence item. View source
  11. Our Story — Gates Foundation (2026) Evidence item GAT-I1; Supports the evidence item. View source
  12. Our Story — Gates Foundation (2026) Evidence item GAT-J1; Supports the evidence item. View source
  13. Twenty years to give away virtually all my wealth — Gates Foundation (2025) Evidence item GAT-J1; Supports the evidence item. View source
  14. United States v. Microsoft Corporation — US Department of Justice (1998) Evidence item GAT-J1; Supports the evidence item. View source
  15. Gavi's impact — Gavi, the Vaccine Alliance (2026) Evidence item GAT-R1; Supports the evidence item. View source
  16. Our Story — Gates Foundation (2026) Evidence item GAT-R1; Supports the evidence item. View source
  17. Twenty years to give away virtually all my wealth — Gates Foundation (2025) Evidence item GAT-V1; Supports the evidence item. View source
  18. United States v. Microsoft Corporation — US Department of Justice (1998) Evidence item GAT-V1; Supports the evidence item. View source
  19. Gavi's impact — Gavi, the Vaccine Alliance (2026) Evidence item GAT-W1; Supports the evidence item. View source
  20. Global Polio Eradication Initiative — World Health Organization (2026) Evidence item GAT-W1; Supports the evidence item. View source
  21. Our Story — Gates Foundation (2026) Evidence item GAT-W1; Supports the evidence item. View source

Correction history

No corrections have been recorded.

Related ethical assessments